These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26056504)

  • 1. Acquired hemophilia A: emerging treatment options.
    Janbain M; Leissinger CA; Kruse-Jarres R
    J Blood Med; 2015; 6():143-50. PubMed ID: 26056504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired hemophilia A: a review of recent data and new therapeutic options.
    Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM
    Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emicizumab as first-line therapy in acquired hemophilia A.
    Iarossi M; Hermans C
    Res Pract Thromb Haemost; 2024 May; 8(4):102438. PubMed ID: 38953052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected postpartum hemorrhage due to an acquired factor VIII inhibitor.
    Paidas MJ; Hossain N
    Am J Perinatol; 2014 Sep; 31(8):645-54. PubMed ID: 24338123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia.
    Losos M; Scrape S; Joshi S; Shmookler A; Chen J
    J Clin Apher; 2017 Dec; 32(6):564-566. PubMed ID: 27646211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur.
    Miatech JL; Kantamani D; Stagg MP
    Cureus; 2021 Oct; 13(10):e19145. PubMed ID: 34868780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review.
    Sella C; Bardetta M; Valeri F; Dainese C; Valpreda A; Massaia M; Grimaldi D; Porreca A; Bruno B; Borchiellini A
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of acquired hemophilia A: Review of current evidence.
    Charlebois J; Rivard GÉ; St-Louis J
    Transfus Apher Sci; 2018 Dec; 57(6):717-720. PubMed ID: 30396835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of spontaneous inhibitors in children with porcine factor VIII.
    Kobrinsky NL; Stegman D; Sjolander D
    Haemophilia; 2002 Jan; 8 Suppl 1():1-4; discussion 28-32. PubMed ID: 11882074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hemophilia a: a current review of autoantibody disease.
    Sborov DW; Rodgers GM
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):19-27. PubMed ID: 22398803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII.
    Nguyen S; Teh P; Zhou J; Chang EY; von Drygalski A
    Case Rep Hematol; 2019; 2019():9026121. PubMed ID: 31559096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer.
    Sheth C; Gill A; Sekhon S
    J Community Hosp Intern Med Perspect; 2016; 6(4):32461. PubMed ID: 27609734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired Hemophilia A in an advanced age patient of hispanic origin: a case report.
    Rivera Cora NI; Irizarry Delgado F; Merle Ramírez SM; Vera Quiñones J
    BMC Res Notes; 2017 Sep; 10(1):438. PubMed ID: 28870236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient.
    Škunca Ž; Peraica AP
    Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Hemophilia A: A Potentially Fatal Bleeding Disorder.
    Singh N; Singh Lubana S; Dabrowski L
    Cureus; 2020 Jun; 12(6):e8744. PubMed ID: 32714682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired haemophilia (acquired factor VIII inhibitor)].
    Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
    Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.